PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,075,000 | -39.1% | 226,500 | -75.9% | 0.00% | -42.9% |
| Q1 2020 | $6,695,000 | +71.8% | 938,997 | +475.2% | 0.01% | +133.3% |
| Q4 2019 | $3,898,000 | +1327.8% | 163,242 | +1523.0% | 0.00% | – |
| Q2 2019 | $273,000 | -97.7% | 10,058 | -97.3% | 0.00% | -100.0% |
| Q2 2018 | $11,967,000 | 0.0% | 366,400 | 0.0% | 0.01% | -46.2% |
| Q1 2018 | $11,967,000 | -30.3% | 366,400 | +3.9% | 0.01% | -31.6% |
| Q4 2017 | $17,174,000 | -39.9% | 352,800 | -33.2% | 0.02% | -44.1% |
| Q3 2017 | $28,555,000 | +34.8% | 528,500 | +40.1% | 0.03% | +25.9% |
| Q2 2017 | $21,187,000 | +477.6% | 377,200 | +133.6% | 0.03% | +350.0% |
| Q3 2016 | $3,668,000 | -55.5% | 161,500 | -53.8% | 0.01% | -62.5% |
| Q2 2016 | $8,246,000 | -14.9% | 349,400 | -26.4% | 0.02% | -11.1% |
| Q1 2016 | $9,686,000 | +35.3% | 474,800 | +241.3% | 0.02% | +12.5% |
| Q4 2015 | $7,157,000 | +605.8% | 139,100 | +484.5% | 0.02% | +700.0% |
| Q3 2015 | $1,014,000 | -18.8% | 23,800 | -13.1% | 0.00% | -33.3% |
| Q2 2015 | $1,248,000 | -45.2% | 27,400 | -54.3% | 0.00% | -40.0% |
| Q1 2015 | $2,276,000 | – | 59,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |